CVS Health’s Vanguard High Dividend Yield ETF VYM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-252,032
Closed -$32.3M 5
2024
Q3
$32.3M Hold
252,032
14.04% 2
2024
Q2
$29.9M Hold
252,032
13.78% 2
2024
Q1
$30.5M Hold
252,032
14.4% 2
2023
Q4
$28.1M Hold
252,032
14.52% 2
2023
Q3
$26M Hold
252,032
13.92% 3
2023
Q2
$26.7M Buy
252,032
+39,200
+18% +$4.11M 13.83% 3
2023
Q1
$22.5M Hold
212,832
13.37% 3
2022
Q4
$23M Hold
212,832
19.85% 2
2022
Q3
$20.2M Hold
212,832
19.4% 2
2022
Q2
$21.6M Sell
212,832
-2,168
-1% -$235K 17.95% 2
2022
Q1
$24.1M Buy
+215,000
New +$24M 16.21% 3

Other funds holding VYM

CVS Health's VYM Position: Q4 2024 in Review

CVS Health sold out of Vanguard High Dividend Yield ETF (VYM) in Q4 2024, closing a stake of 252,032 shares — an estimated $32.3M sold.

CVS Health first reported a position in VYM in Q1 2022 and held it in 11 quarters. The position peaked at $32.3M in Q3 2024. 1,797 funds tracked by Wall St. Rank hold VYM as of Q4 2024.

  • CVS Health reported no remaining Vanguard High Dividend Yield ETF position as of Q4 2024 after selling out during the quarter.
  • CVS Health sold 252,032 Vanguard High Dividend Yield ETF shares in Q4 2024, an estimated $32.3M.
  • CVS Health first reported a position in Vanguard High Dividend Yield ETF in Q1 2022 and held it in 11 quarters.
  • CVS Health's Vanguard High Dividend Yield ETF position peaked at $32.3M in Q3 2024.
  • 1,797 funds tracked by Wall St. Rank held Vanguard High Dividend Yield ETF as of Q4 2024.

Based on CVS Health's 13F filing for Q4 2024, filed 13 Feb 2025.